Enimmune Biotech Overview
- Year Founded
-
2014
- Status
-
IPO Registration
- Employees
-
36
- Latest Deal Type
-
IPO
- (Announced)
- Investors
-
3
Enimmune Biotech General Information
Description
Enimmune Corp is primarily engaged in the research and development and trading of vaccines, testing reagents and biotechnology services, etc., as well as trading of related western medicines.
Contact Information
Website
www.enimmune.com.twCorporate Office
- 18 F.-2, No. 76, Sec. 2, Dunhua S. Rd.
- Daan District
- Taipei
- Taiwan
Corporate Office
- 18 F.-2, No. 76, Sec. 2, Dunhua S. Rd.
- Daan District
- Taipei
- Taiwan
Enimmune Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. IPO | 09-Jul-2024 | Announced | Generating Revenue | |||
| 2. Later Stage VC | 01-Jan-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jun-2015 | Completed | Generating Revenue |
Enimmune Biotech Signals
Enimmune Biotech Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Diamond Biofund | Venture Capital | Minority | ||
| Maxceed Capital | Family Office | Minority | ||
| Chung Ying Investment Development Company | Asset Manager | Minority |
Enimmune Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Enimmune Biotech FAQs
-
When was Enimmune Biotech founded?
Enimmune Biotech was founded in 2014.
-
Where is Enimmune Biotech headquartered?
Enimmune Biotech is headquartered in Taipei, Taiwan.
-
What is the size of Enimmune Biotech?
Enimmune Biotech has 36 total employees.
-
What industry is Enimmune Biotech in?
Enimmune Biotech’s primary industry is Drug Discovery.
-
Is Enimmune Biotech a private or public company?
Enimmune Biotech is a Private company.
-
What is Enimmune Biotech’s current revenue?
The current revenue for Enimmune Biotech is .
-
Who are Enimmune Biotech’s investors?
Diamond Biofund, Maxceed Capital, and Chung Ying Investment Development Company have invested in Enimmune Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process